Yudhanto, Didit and Wardoyo, Eustachius Hagni and Asmara, I Gede Yasa (2019) Antimicrobial restriction policy in West Nusa Tenggara General Hospital in Antimicrobial Stewardship Program Implementation. Seminar Nasional Saintek Universitas Mataram 2019. (In Press)
![[img]](http://eprints.unram.ac.id/style/images/fileicons/text.png) |
Text
Didit Yudhanto dkk - Antimicrobial restriction policy in West Nusa Tenggara General Hospital in Antimicrobial Stewardship Program implementation.docx Download (16kB) |
Abstract
Background: Antimicrobial Stewardship Program (ASP) implementation in an accredited hospital is a must. There are three phases to follow in ASP implementation: preparation, implementation and monitoring. Currently in West Nusa Tenggara General Hospital (WNTGH) is in implementation phase. Preparation phase: program development, antimicrobial use policy; Implementation phase: sosialization for the program and policy, pilot project of a program. Vancomycin restriction policy is pilot project of an ASP Program implementation for inpatient in WNTGH in 2018. General statement of restriction is: “The prescription of vancomycin is dedicated only for infection that is caused by methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus sp (Vancomycin-Sensitive Enterococci) and other Gram positive organisms.” Aim: To describe vancomycin restriction policy to the reduce prescription Methods: A quantitive analysis of overall vancomycin prescription is overlooked in 2017, 2018 and 2019 (until june). All medical record with vancomycin prescription in 2018 is evaluated: the culture results, clinical diagnosis, clinical outcome and related with vancomycin financial spending (an ongoing process). CAV=case asking for Vancomycin Results: Sixty one cases are ask for vancomycin (CAV); 21 female and 39 male, median age 23 yrs (0-82 yrs). Overall, there were 39 positive culture, 5 negative culture and 17 no culture data. All of that was approved for vancomycin prescription; in 2017 with no microbiological data previously (clinical syndromes, clinical worsening, no improvement with previous antibiotics); in 2018 is based on microbiological data; in 2019 with Gram positive result only. Conclusion: There were better selection criteria CAV only for Gram positive organisms in 2018. There is increasing awareness to reduce the use of vancomycin in clinicians.
| Item Type: | Article |
|---|---|
| Keywords (Kata Kunci): | Antimicrobial Stewardship Program, vancomycin restriction policy |
| Subjects: | R Medicine > R Medicine (General) |
| Divisions: | Fakultas Kedokteran |
| Depositing User: | Dr Eustachius Hagni Wardoyo |
| Date Deposited: | 03 Dec 2019 01:12 |
| Last Modified: | 03 Dec 2019 01:12 |
| URI: | http://eprints.unram.ac.id/id/eprint/15089 |
Actions (login required)
 |
View Item |
